<unk>  is an immunological agent that is FDA approved for the treatment of asymptomatic or minimally symptomatic metastatic castrate resistant (hormone refractory) prostate cancer.   Common adverse reactions include nausea, vomiting, anemia, backache, headache, citrate adverse reaction, fatigue, fever, Infusion reaction, pain, rigor, shivering.
Sipuleucel-T
Becaplermin
Cevimeline
Dimetan
Oxydeprofos
Isoprocarb
Rubitecan
Crofelemer